Report #2840117

Received May 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	UNK	—	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

innapropriate schedule of vaccine administered; no adverse event; This spontaneous report has been received from a consumer regarding a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant therapies was not reported. On an unspecified date, the patient received the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (GARDASIL 9) for prophylaxis (strength, dose, anatomical site, route of administration, lot number and expiration date not reported). On an unknown date after 2 years of first vaccination, the patient received the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant Suspension for injection (GARDASIL 9) for prophylaxis (strength, dose, anatomical site, route of administration, lot number and expiration date not reported) (Inappropriate schedule of vaccine administered) (no adverse event).